~~NOTOC~~
====== Supreme Court ======

===== Upcoming S.Ct. patent cases of interest (posted 01/04/22) =====

Law360 published [[law360>ip/articles/1444784/patent-cases-to-watch-in-2022-|an article]] ({{ :private:20220103_law360_cases_to_watch.maff |cached - private}}) identifying cases that might be taken up by the Supreme Court in 2022:

  * **Eligibility:**  //American Axle v. Neapco//.  In response to an en banc petition, the Fed. Cir. issued 100+ pages of rulings, leaving panel decision in place.  On appeal to the S.Ct., the Justices, in May, asked for the solictor general to file a brief which is yet to be submitted.
    * [[sb>case-files/cases/american-axle-manufacturing-inc-v-neapco-holdings-llc/|Track]] 
    * <fc #800000>Update:  Petition denied 6/30/22</fc>
  * **Kessler Doctrine/patent exceptionalism:**  //PersonalWeb v. Patereon//.
    * [[sb>case-files/cases/personalweb-technologies-llc-v-patreon-inc/|Track]]
    * <fc #800000>Update:  Petition denied 05/16/22</fc>
  * **Fintiv Rule:**  //Apple v. Hirschfeld//; //Apple v. Optis//; //Mylan v. Janssen//; //Intel v. VLSI//.  
    * [[sb>https://www.scotusblog.com/case-files/cases/302710/|Track Apple v. Optis]]
    * <fc #800000>Update:  Petition denied 01/18/22</fc>
  * **Inducement/"skinny labels":**  //GlaxoSmithKline v. Teva//.  The Fed. Cir. is pondering an en-banc petition.
    * [[fcb>en-banc/petitions/glaxosmithkline-llc-v-teva-pharmaceuticals-usa-inc/|Track]]  
    * {{ :legal:infringement:glaxosmithkline_en-banc_petition.pdf |En banc petition}}
    * [[pd>2022/02/glaxosmithkline-llc-v-teva-pharmnaceuticals-usa-fed-cir-2022.html|Detailed analysis]]  8-)
    * <fc #800000>Update: Petition for en banc review denied 08/05/21.</fc>